Clinical Trials Browser

Phase 3 × Opsoclonus-Myoclonus Syndrome × Rituximab × Clear all

NCT01868269 2025-02-03

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

Phase 3 Completed

Neuroblastoma, Opsoclonus-Myoclonus Syndrome